Furthermore, a study conducted by Khan et al. in veteran patients with IBD receiving different immunosuppressive medications found that among the 6578 patients with full vaccination status, no SARS-CoV-2 infections were identified among those taking anti-TNF agents, or ustekinumab [21]. Here, TNF is linked to inflammatory bowel disease.